![Joris Schuurmans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joris Schuurmans
Chief Executive Officer at Cergentis BV
Joris Schuurmans active positions
Companies | Position | Start | End |
---|---|---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Chief Operating Officer | 01/06/2013 | - |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Chief Executive Officer | 01/06/2020 | - |
Career history of Joris Schuurmans
Former positions of Joris Schuurmans
Companies | Position | Start | End |
---|---|---|---|
BIOCARTIS GROUP NV | Chief Operating Officer | - | - |
Statistics
International
Switzerland | 2 |
Belgium | 2 |
Netherlands | 2 |
Operational
Chief Operating Officer | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIOCARTIS GROUP NV | Health Technology |
Private companies | 2 |
---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Commercial Services |
- Stock Market
- Insiders
- Joris Schuurmans
- Experience